Latest filing published 23 Feb 2021 for BRADY CORP, €95k.
Insider track record
Closed purchases
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -5.9%Entry US$34.50 · Close at T+365 US$32.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gary S. Balkema: trading record in brief
Gary S. Balkema has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Brady Corp and PLx Pharma Inc. We count 40 filings; the first trade dates from 14 September 2010 and the latest from 22 February 2021.
On the market, this insider has only ever bought: 12 purchases, €42k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 25 share grants and 3 option exercises.
A typical purchase (the median) is worth €2,118. Looking at 9 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -1.9%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 23 February 2021: an option exercise of €95k, in Brady Corp. The last insider purchase was made public on 22 February 2011, 5,739 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gary S. Balkema
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,250 shares@ US$27.005.9% of flowClass A Common StockSEC:0000746598-21-000027:0
- 2,266 shares@ US$50.645.9% of flowClass A Common StockSEC:0000746598-21-000027:1
- 2,731 shares@ US$39.928.7% of flowClass A Common StockSEC:0000746598-20-000186:0
- 10,000 shares@ US$28.3522.4% of flowClass A Common StockSEC:0000746598-20-000027:0
- 5,658 shares@ US$50.1122.4% of flowClass A Common StockSEC:0000746598-20-000027:1
- 8,400 shares@ US$29.1019.3% of flowClass A Common StockSEC:0000746598-20-000027:2
- 4,878 shares@ US$50.1119.3% of flowClass A Common StockSEC:0000746598-20-000027:3
- 2,017 shares@ US$54.057.9% of flowClass A Common StockSEC:0000746598-19-000197:0
- 2,479 shares@ US$43.987.4% of flowClass A Common StockSEC:0000746598-18-000149:0
- 2,579 shares@ US$36.855.6% of flowClass A Common StockSEC:0000746598-17-000119:0
- 1,450 shares@ US$26.43Class A Common StockSEC:0000746598-17-000071:0
- 5,445 sharesCommon StockSEC:0001144204-17-021377:0
- 2,704 shares@ US$35.146.0% of flowClass A Common StockSEC:0000746598-16-000320:0
- 39 shares@ US$23.05Class A Common StockSEC:0000746598-15-000124:0
- 34 shares@ US$26.93Class A Common StockSEC:0000746598-15-000075:0
- 33 shares@ US$27.54Class A Common StockSEC:0000746598-15-000029:0
- 37 shares@ US$24.20Class A Common StockSEC:0000746598-14-000210:0
- 22 shares@ US$26.12Class A Common StockSEC:0000746598-14-000099:0
- 22 shares@ US$26.19Class A Common StockSEC:0000746598-14-000059:0
- 22 shares@ US$27.14Class A Common StockSEC:0000746598-14-000022:0
- 19 shares@ US$28.84Class A Common StockSEC:0000746598-13-000250:0
- 9 shares@ US$33.88Class A Common StockSEC:0000746598-13-000150:0
- 7 shares@ US$33.51Class A Common StockSEC:0000746598-13-000095:0
- 8 shares@ US$35.04Class A Common StockSEC:0000746598-13-000027:0
- 100 shares@ US$27.50Class A Common StockSEC:0001497486-11-000005:0Canonical exit: 13 Dec 2010 (T+90)
25 of 33 declarations
